Asset Details
Do you wish to reserve the book?
The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era
Do you wish to request the book?
The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era
2023
Overview
In The Lancet Infectious Diseases, Niklas Bobrovitz and colleagues3 present the results of a well-conducted systematic review and meta-analysis investigating the long-term benefit of SARS-CoV-2 vaccines in individuals who have developed hybrid immunity. Several countries still face vaccine shortages, and the benefit of offering multiple booster doses should be discussed in light of the findings of the present study.3 Even though nearly 70% of the world's population has received at least one SARS-CoV-2 vaccine dose, the distribution of vaccine coverage remains unequal. Fiocruz allocates all its manufactured products to the Ministry of Health in Brazil for public health use.
Publisher
Elsevier Ltd,Elsevier Limited
